Subcutaneous defibrillators for dialysis patients

Tushar J. Vachharajani, Loay Salman, Eric J. Costanzo, Sushil K. Mehandru, Mayurkumar Patel, Dawn M. Calderon, Roy O. Mathew, Mandeep S. Sidhu, Arif Asif

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement. Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.

Original languageEnglish (US)
JournalHemodialysis International
DOIs
StateAccepted/In press - 2017

Keywords

  • Dialysis catheter
  • Hemodialysis
  • Subcutaneous defibrillator

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Fingerprint Dive into the research topics of 'Subcutaneous defibrillators for dialysis patients'. Together they form a unique fingerprint.

  • Cite this

    Vachharajani, T. J., Salman, L., Costanzo, E. J., Mehandru, S. K., Patel, M., Calderon, D. M., Mathew, R. O., Sidhu, M. S., & Asif, A. (Accepted/In press). Subcutaneous defibrillators for dialysis patients. Hemodialysis International. https://doi.org/10.1111/hdi.12577